Groundbreaking Approval: AstraZeneca’s FluMist Nasal Spray Vaccine Gets FDA Green Light for Self-Administration (Multibagger) – In a revolutionary move, the U.S. Food and Drug Administration (FDA) has approved AstraZeneca’s (NASDAQ: AZN) FluMist nasal spray vaccine for self-administration. This landmark approval makes FluMist the first influenza…

Read More

Opinion

Sports

Money

Tech & Innovation